Creative Planning raised its stake in Veradigm Inc. (NASDAQ:MDRX – Free Report) by 53.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 16,089 shares of the software maker’s stock after purchasing an additional 5,622 shares during the quarter. Creative Planning’s holdings in Veradigm were worth $203,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Cerity Partners LLC purchased a new position in shares of Veradigm in the 1st quarter valued at approximately $804,000. Gladius Capital Management LP acquired a new stake in shares of Veradigm in the 1st quarter worth $28,000. Quarry LP acquired a new stake in shares of Veradigm in the 1st quarter worth $37,000. Advisor Group Holdings Inc. lifted its stake in shares of Veradigm by 15.6% in the 4th quarter. Advisor Group Holdings Inc. now owns 4,833 shares of the software maker’s stock worth $85,000 after acquiring an additional 651 shares during the period. Finally, Prelude Capital Management LLC acquired a new stake in shares of Veradigm in the 2nd quarter worth $156,000.
Analysts Set New Price Targets
MDRX has been the subject of a number of analyst reports. StockNews.com initiated coverage on Veradigm in a research note on Sunday. They set a “hold” rating for the company. Deutsche Bank Aktiengesellschaft cut their target price on Veradigm from $21.00 to $18.00 in a research note on Friday, June 30th. Stephens reaffirmed an “equal weight” rating and set a $13.00 price target on shares of Veradigm in a research note on Tuesday, October 10th. Finally, Argus cut shares of Veradigm from a “buy” rating to a “hold” rating in a research note on Thursday, July 6th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $19.36.
Veradigm Stock Down 2.4 %
NASDAQ:MDRX opened at $13.02 on Thursday. The company has a market capitalization of $1.42 billion, a PE ratio of 30.28 and a beta of 0.92. Veradigm Inc. has a 52-week low of $11.30 and a 52-week high of $19.77. The stock has a fifty day simple moving average of $13.17 and a 200-day simple moving average of $12.73.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- 3 Healthcare Dividend Stocks to Buy
- The top 3 stocks insiders are selling, but you shouldn’t
- How to Calculate Options Profits
- Spirit AeroSystems Goes Airborne After Inking a Boeing Deal
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Simon Property Group’s 7.2% Dividend Has Insiders Buying In Bulk
Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veradigm Inc. (NASDAQ:MDRX – Free Report).
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
